Oxford/AstraZeneca: AZD1222

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Vaxzevria

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 7 Trials

Phase 2: 27 Trials

Phase 3: 11 Trials

This vaccine is also manufactured by the Serum Institute of India (Covishield)

Registered Trials